查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529599

病人参与中的人工智慧市场规模、份额和趋势分析报告：按技术、按交付类型、按功能、按治疗领域、按最终用途、按地区、细分市场预测，2024-2030 年

AI In Patient Engagement Market Size, Share & Trends Analysis Report By Technology, By Delivery Type, By Functionality, By Therapeutic Area, By End Use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

人工智慧市场成长与病人参与趋势：

Grand View Research, Inc. 的最新报告显示，到 2030 年，全球人工智慧病人参与市场规模预计将达到 231 亿美元，2024 年至 2030 年复合年增长率为 21.2%。

该市场的推动因素包括对基于人工智慧的个人化治疗计划和医疗保健体验的需求不断增长，以及数位平台的出现和对全通路方法的需求。此外，人工智慧（AI）在市场参与者的商务策略中发挥越来越重要的作用，以提高药房效率、管理供应链复杂性和业务策略，这也推动了市场的成长。例如，2024 年 5 月，EmpiRx Health 宣布推出 Clinically，这是一个新的人工智慧驱动平台，融合了现有技术。该平台为药房申请处理和临床评估提供支持，由专有的人口健康引擎提供支持，并为 EmpiRx Health 以临床为重点的药房福利管理 (PBM) 方法提供支援。

此外，糖尿病和高血压等慢性病的盛行率不断上升，需要患者持续参与和管理，而人工智慧可以有效促进这一点。此外，机器学习和自然语言处理 (NLP) 等人工智慧技术可以透过提供个人化支援和介入来显着提高病人参与。这些技术分析患者资料并提供量身定制的建议、提醒和教育内容，以提高依从性和健康结果。例如，2022 年 3 月，Unifor 与病人参与解决方案提供者 SpinSci Technologies 建立了策略合作伙伴关係，以改善患者访问以及与医疗保健提供者的互动。此次合作将 Unifor 的对话式人工智慧和自动化技术整合到 SpinSci Technologies 的患者访问护理解决方案中，该解决方案与电子健康记录(EHR) 系统相容。这种整合旨在提高客服中心代理效率并简化患者自助服务工作流程。

人工智慧的整合使医疗保健提供者能够根据患者的个人偏好、健康素养水平和语言熟练程度提供量身定制的教育内容，从而提高患者的参与度和治疗计划的依从性。例如，2024 年 2 月，Accolade Group 支援的创业平台 Ascend 宣布打算利用人工智慧提供针对特定需求的教育和医疗保健服务。由于这些努力，患者教育功能部分预计将显着成长，并将推动未来几年的整体市场扩张。

北美市场也将受益于人工智慧的整合，这将使医疗机构能够根据患者的个人偏好、健康素养水平和语言熟练程度提供客製化的教育内容，从而提高患者的参与度和治疗计划的依从性。例如，2024 年 2 月，Accolade Group 支援的创业平台 Ascend 宣布打算利用人工智慧提供针对特定需求的教育和医疗保健服务。由于这些倡议，患者教育功能部分预计将显着成长，并将推动未来几年的整体市场扩张。

病人参与市场中的人工智慧报告亮点

  • 从交付形式来看，云端基础的细分市场占据主导地位，2023 年收益占有率为 72.37%。云端基础的解决方案提供可扩展的资源，使医疗保健组织能够根据需求波动调整容量。
  • 按功能划分，通讯增强占最大销售份额，2023 年为 25.84%。人工智慧主导的解决方案在医疗保健领域的日益整合正在推动对增强通讯能力的需求。
  • 从技术来看，自然语言处理（NLP）占最大收益占有率， 2023年将达到88.82%。此细分市场的成长归功于 NLP 模型提供的多项好处，例如透过提供量身定制且易于理解的健康资讯来提高病人参与和教育水平。
  • 以治疗领域来看，慢病管理占最大的销售份额，2023年为64.87%。这一领域的成长是由于糖尿病、高血压和心臟病等慢性病的盛行率不断增加。
  • 按最终用途划分，医疗保健提供者产业在 2023 年占据最大收益占有率，达到 38.31%。对以患者为中心的护理的日益关注、对更好的资源利用的需求的增加以及对个性化医疗保健体验的需求不断增长正在推动医疗保健提供者采用人工智慧来促进病人参与。
  • 2023 年，北美市场占据主导地位，份额为 43.60%。这一重要份额的关键因素包括拥有先进技术的成熟医疗基础设施、人们对整合人工智慧病人参与解决方案的好处的认识不断提高，以及个性化的医疗体验和治疗，其中包括对规划的日益偏好。
  • 由于存在多个参与者，市场变得分散。因此，预计未来几年竞争将会加剧。大公司越来越多地采取新产品开发、联盟和併购等策略来巩固其市场地位。 2024 年 6 月，MedAdvisor Solutions 宣布推出由 THRiV 提供支援的人工智慧平台全通路参与药局。该套件使药局能够加强现有的工作，包括数位化病人参与策略和提供患者喜欢的无纸化选择。

目录

第一章调查方法和范围

第 2 章执行摘要

第 3 章：病人参与市场中的人工智慧变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 病人参与市场分析工具中的人工智慧 (AI)
    • 产业分析-波特五力分析
    • PESTEL分析
    • COVID-19 的影响
    • 案例研究

第 4 章病人参与的人工智慧市场估计和趋势分析：按产品类型

  • 2023年及2030年市场占有率
  • 细分仪表板
  • 全球市场展望
  • 云端基础
    • 2018年至2030年市场预测
  • 本地
    • 2018年至2030年市场预测

第五章病人参与的人工智慧市场估计和趋势分析：按功能

  • 2023年及2030年市场占有率
  • 细分仪表板
  • 全球市场展望
  • 加强沟通
    • 2018年至2030年市场预测
  • 病患教育
    • 2018年至2030年市场预测
  • Chabot 和虚拟健康助手
    • 2018年至2030年市场预测
  • 预测分析
    • 2018年至2030年市场预测
  • 管理和简化营运
    • 2018年至2030年市场预测
  • 其他的
    • 2018年至2030年市场预测

第 6 章病人参与方面的人工智慧市场估计和趋势分析：按技术类型

  • 2023年及2030年市场占有率
  • 细分仪表板
  • 全球市场展望
  • NLP
    • 2018年至2030年市场预测
    • 智慧援助
    • 光学字元辨识 (OCR)
    • 自动编码
    • 文字分析
    • 语音分析
    • 分类与分类
  • 其他的
    • 2018年至2030年市场预测

第 7 章病人参与的人工智慧市场估计和趋势分析：按治疗领域

  • 2023年及2030年市场占有率
  • 细分仪表板
  • 全球市场展望
  • 健康与保健
    • 2018年至2030年市场预测
  • 慢性病管理
    • 2018年至2030年市场预测
  • 其他的
    • 2018年至2030年市场预测

第 8 章病人参与中的人工智慧市场估计和趋势分析：按最终用途

  • 2023年及2030年市场占有率
  • 细分仪表板
  • 全球市场展望
  • 医疗服务提供方
    • 2018年至2030年市场预测
  • 医疗保健付款人
    • 2018年至2030年市场预测
  • 其他的
    • 製药公司
    • 药局

第 9 章病人参与市场中的人工智慧区域估计和趋势分析（按组件和技术类型）

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概述
  • 2018-2030年市场规模、预测趋势分析：
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 新加坡
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第10章竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 创新者
  • 供应商情况
    • 2023年主要企业市场地位分析
    • Medadvisor Solutions
    • Innovaccer Inc.
    • EnlivenHealth（Omnicell）
    • EmpiRx Health
    • IBM.
    • Huma
    • mPulse Mobile
    • AllazoHealth
    • P360
    • Brand Engagement Network, Inc.
    • Oracle
    • Nuance Communications Inc.（Microsoft）
    • Health Catalyst
    • Ada Health GmbH
    • Aiva Inc.
    • Claritas Rx
    • AiCure
    • UST Global Inc.
    • ZS
    • IQVIA, Inc.
Product Code: GVR-4-68040-145-8

AI In Patient Engagement Market Growth & Trends:

The global AI in patient engagement market size is expected to reach USD 23.1 billion by 2030, registering a CAGR of 21.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is driven by the growing demand for AI-based personalized treatment plans and healthcare experiences and the emergence of digital platforms and necessity for omnichannel approach. In addition, the increasing role of artificial intelligence (AI) in enhancing pharmacy efficiency and managing supply chain complexities and business strategies by market players is also driving the market growth. For instance, in May 2024, EmpiRx Health introduced Clinically, a new AI-powered platform that incorporates established technologies. This platform enhances pharmacy claims processing and clinical evaluations and includes a unique population health engine, reinforcing EmpiRx Health's clinical-focused Pharmacy Benefit Management (PBM) approach.

Moreover, the growing prevalence of chronic diseases, such as diabetes and hypertension, necessitates continuous patient engagement & management, which AI can effectively facilitate. Furthermore, AI technologies such as machine learning and natural language processing (NLP) can significantly enhance patient engagement by providing personalized support & interventions. These technologies analyze patient data to offer tailored recommendations, reminders, & educational content, improving adherence and health outcomes. For instance, in March 2022, Uniphore entered into a strategic partnership with SpinSci Technologies, a provider of digital patient engagement solutions, to improve patient access and interaction with healthcare providers. This collaboration integrated Uniphore's conversational AI and automation technology into SpinSci Technologies Patient Access Care solutions, which are compatible with Electronic Health Records (EHR) systems. The integration aimed to enhance efficiency for contact center agents and streamline patient self-service workflows.

The integration of AI enables healthcare organizations to deliver tailored educational content based on individual patient preferences, health literacy levels, and language proficiency, thereby improving patient engagement & adherence to treatment plans. For instance, in February 2024, Ascend, a startup platform backed by the Accolade Group, announced its intention to deliver educational and healthcare services tailored to specific requirements utilizing AI. As a result of such initiatives, the patient education functionality segment is expected to witness substantial growth, driving overall market expansion in the coming years.

In addition, the market in North America is driven by the integration of AI, enabling healthcare organizations to deliver tailored educational content based on individual patient preferences, health literacy levels, and language proficiency, thereby improving patient engagement & adherence to treatment plans. For instance, in February 2024, Ascend, a startup platform backed by the Accolade Group, announced its intention to deliver educational and healthcare services tailored to specific requirements utilizing AI. As a result of such initiatives, the patient education functionality segment is expected to witness substantial growth, driving overall market expansion in the coming years.

AI In Patient Engagement Market Report Highlights:

  • On the basis of delivery mode, the cloud-based segment dominated the market and held a revenue share of 72.37% in 2023. Cloud-based solutions provide scalable resources, enabling healthcare organizations to adjust capacity according to demand fluctuations
  • On the basis of functionality, enhanced communication held the largest revenue share of 25.84% in 2023. The growing integration of AI-driven solutions in the healthcare sector is driving the need for enhanced communication capabilities
  • On the basis of technology, Natural Language Processing (NLP) held the largest revenue share of 88.82% in 2023. The segment growth can be attributed to several benefits offered by NLP models such as improved patient engagement and education through the provision of tailored & comprehensible health information
  • On the basis of therapeutic area, chronic disease management held the largest revenue share of 64.87% in 2023. The segment growth can be attributed to the increasing prevalence of chronic conditions such as diabetes, hypertension, and heart disease
  • On the basis of end use, the healthcare providers segment held the largest revenue share of 38.31% in 2023. The increasing focus on patient-centric care, coupled with the growing need for effective use of resources and a rising demand for personalized healthcare experiences, is driving healthcare providers to adopt AI for patient engagement
  • North America dominated the market with a share of 43.60% in 2023. Key factors contributing to this notable share include the presence of a well-established healthcare infrastructure equipped with advanced technology, increasing awareness of the advantages of integrating AI-enabled patient engagement solutions, and a growing preference for personalized healthcare experiences & treatment plans
  • The market is fragmented owing to the presence of several players. This is expected to intensify the competition in the coming years. Key companies are increasingly adopting strategies such as new product development, collaborations, and mergers & acquisitions to strengthen their market position. In June 2024, MedAdvisor Solutions announced the launch of Omnichannel Engagement for Pharmacy powered by THRiV, its AI-enabled platform. This suite enables pharmacies to enhance their digital patient engagement strategies and existing initiatives, including providing paperless options increasingly preferred by patients

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Technology
    • 1.1.2. Therapeutic Area
    • 1.1.3. Functionality
    • 1.1.4. Delivery Type
    • 1.1.5. End Use
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology Outlook
    • 2.2.2. Therapeutic Area Outlook
    • 2.2.3. Functionality Outlook
    • 2.2.4. Delivery Outlook
    • 2.2.5. End Use Outlook
    • 2.2.6. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Artificial Intelligence (AI) in Patient Engagement Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Artificial Intelligence (AI) in Patient Engagement Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Impact of COVID-19
    • 3.3.4. Case Study

Chapter 4. Artificial Intelligence (AI) in Patient Engagement Market Delivery Type Estimates & Trend Analysis

  • 4.1. Delivery Type Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Artificial Intelligence (AI) in Patient Engagement Market by Delivery Type Outlook
  • 4.4. Cloud-based
    • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. On-premise
    • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Artificial Intelligence (AI) in Patient Engagement Market Functionality Estimates & Trend Analysis

  • 5.1. Functionality Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Artificial Intelligence (AI) in Patient Engagement Market by Functionality Outlook
  • 5.4. Enhanced Communication
    • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5. Patient Education
    • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.6. Chabot & Virtual Health Assistants
    • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.7. Predictive Analytics
    • 5.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.8. Administrative & Streamlined Operations
    • 5.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Artificial Intelligence (AI) in Patient Engagement Market Technology Type Estimates & Trend Analysis

  • 6.1. Technology Type Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Artificial Intelligence (AI) in Patient Engagement Market by Technology Type Outlook
  • 6.4. NLP
    • 6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.4.2. Smart Assistance
      • 6.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.4.3. Optical Character Recognition (OCR)
      • 6.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.4.4. Auto Coding
      • 6.4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.4.5. Text Analytics
      • 6.4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.4.6. Speech Analytics
      • 6.4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.4.7. Classification & Categorization
      • 6.4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 6.5.1.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Artificial Intelligence (AI) in Patient Engagement Market Therapeutic Area Estimates & Trend Analysis

  • 7.1. Therapeutic Area Market Share, 2023 & 2030
  • 7.2. Segment Dashboard
  • 7.3. Global Artificial Intelligence (AI) in Patient Engagement Market by Therapeutic Area Outlook
  • 7.4. Health & Wellness
    • 7.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 7.5. Chronic Disease Management
    • 7.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. Artificial Intelligence (AI) in Patient Engagement Market End Use Estimates & Trend Analysis

  • 8.1. End Use Market Share, 2023 & 2030
  • 8.2. Segment Dashboard
  • 8.3. Global Artificial Intelligence (AI) in Patient Engagement Market by End Use Outlook
  • 8.4. Healthcare Provider
    • 8.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 8.5. Healthcare Payers
    • 8.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 8.6. Others
    • 8.6.1. Pharmaceutical Companies
      • 8.6.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 8.6.2. Pharmacy
      • 8.6.2.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 9. Artificial Intelligence (AI) in Patient Engagement Market Regional Estimates & Trend Analysis, By Component, By Technology Type

  • 9.1. Regional Market Share Analysis, 2023 & 2030
  • 9.2. Regional Market Dashboard
  • 9.3. Global Regional Market Snapshot
  • 9.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 9.5. North America
    • 9.5.1. U.S.
      • 9.5.1.1. Key country dynamics
      • 9.5.1.2. Regulatory framework/ reimbursement structure
      • 9.5.1.3. Competitive scenario
      • 9.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.2. Canada
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework/ reimbursement structure
      • 9.5.2.3. Competitive scenario
      • 9.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.3. Mexico
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Regulatory framework/ reimbursement structure
      • 9.5.3.3. Competitive scenario
      • 9.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6. Europe
    • 9.6.1. UK
      • 9.6.1.1. Key country dynamics
      • 9.6.1.2. Regulatory framework/ reimbursement structure
      • 9.6.1.3. Competitive scenario
      • 9.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.2. Germany
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Regulatory framework/ reimbursement structure
      • 9.6.2.3. Competitive scenario
      • 9.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.3. France
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Regulatory framework/ reimbursement structure
      • 9.6.3.3. Competitive scenario
      • 9.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.4. Italy
      • 9.6.4.1. Key country dynamics
      • 9.6.4.2. Regulatory framework/ reimbursement structure
      • 9.6.4.3. Competitive scenario
      • 9.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.5. Spain
      • 9.6.5.1. Key country dynamics
      • 9.6.5.2. Regulatory framework/ reimbursement structure
      • 9.6.5.3. Competitive scenario
      • 9.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.6. Norway
      • 9.6.6.1. Key country dynamics
      • 9.6.6.2. Regulatory framework/ reimbursement structure
      • 9.6.6.3. Competitive scenario
      • 9.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.7. Sweden
      • 9.6.7.1. Key country dynamics
      • 9.6.7.2. Regulatory framework/ reimbursement structure
      • 9.6.7.3. Competitive scenario
      • 9.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.8. Denmark
      • 9.6.8.1. Key country dynamics
      • 9.6.8.2. Regulatory framework/ reimbursement structure
      • 9.6.8.3. Competitive scenario
      • 9.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7. Asia Pacific
    • 9.7.1. Japan
      • 9.7.1.1. Key country dynamics
      • 9.7.1.2. Regulatory framework/ reimbursement structure
      • 9.7.1.3. Competitive scenario
      • 9.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.2. China
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Regulatory framework/ reimbursement structure
      • 9.7.2.3. Competitive scenario
      • 9.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.3. India
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Regulatory framework/ reimbursement structure
      • 9.7.3.3. Competitive scenario
      • 9.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.4. Australia
      • 9.7.4.1. Key country dynamics
      • 9.7.4.2. Regulatory framework/ reimbursement structure
      • 9.7.4.3. Competitive scenario
      • 9.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.5. South Korea
      • 9.7.5.1. Key country dynamics
      • 9.7.5.2. Regulatory framework/ reimbursement structure
      • 9.7.5.3. Competitive scenario
      • 9.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.6. Singapore
      • 9.7.6.1. Key country dynamics
      • 9.7.6.2. Regulatory framework/ reimbursement structure
      • 9.7.6.3. Competitive scenario
      • 9.7.6.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.8. Latin America
    • 9.8.1. Brazil
      • 9.8.1.1. Key country dynamics
      • 9.8.1.2. Regulatory framework/ reimbursement structure
      • 9.8.1.3. Competitive scenario
      • 9.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.8.2. Argentina
      • 9.8.2.1. Key country dynamics
      • 9.8.2.2. Regulatory framework/ reimbursement structure
      • 9.8.2.3. Competitive scenario
      • 9.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.9. MEA
    • 9.9.1. South Africa
      • 9.9.1.1. Key country dynamics
      • 9.9.1.2. Regulatory framework/ reimbursement structure
      • 9.9.1.3. Competitive scenario
      • 9.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.9.2. Saudi Arabia
      • 9.9.2.1. Key country dynamics
      • 9.9.2.2. Regulatory framework/ reimbursement structure
      • 9.9.2.3. Competitive scenario
      • 9.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.9.3. UAE
      • 9.9.3.1. Key country dynamics
      • 9.9.3.2. Regulatory framework/ reimbursement structure
      • 9.9.3.3. Competitive scenario
      • 9.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.9.4. Kuwait
      • 9.9.4.1. Key country dynamics
      • 9.9.4.2. Regulatory framework/ reimbursement structure
      • 9.9.4.3. Competitive scenario
      • 9.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2. Company/Competition Categorization
  • 10.3. Innovators
  • 10.4. Vendor Landscape
    • 10.4.1. Key company market position analysis, 2023
    • 10.4.2. Medadvisor Solutions
      • 10.4.2.1. Company overview
      • 10.4.2.2. Financial performance
      • 10.4.2.3. Product benchmarking
      • 10.4.2.4. Strategic initiatives
    • 10.4.3. Innovaccer Inc.
      • 10.4.3.1. Company overview
      • 10.4.3.2. Financial performance
      • 10.4.3.3. Product benchmarking
      • 10.4.3.4. Strategic initiatives
    • 10.4.4. EnlivenHealth (Omnicell)
      • 10.4.4.1. Company overview
      • 10.4.4.2. Financial performance
      • 10.4.4.3. Product benchmarking
      • 10.4.4.4. Strategic initiatives
    • 10.4.5. EmpiRx Health
      • 10.4.5.1. Company overview
      • 10.4.5.2. Financial performance
      • 10.4.5.3. Product benchmarking
      • 10.4.5.4. Strategic initiatives
    • 10.4.6. IBM.
      • 10.4.6.1. Company overview
      • 10.4.6.2. Financial performance
      • 10.4.6.3. Product benchmarking
      • 10.4.6.4. Strategic initiatives
    • 10.4.7. Huma
      • 10.4.7.1. Company overview
      • 10.4.7.2. Financial performance
      • 10.4.7.3. Product benchmarking
      • 10.4.7.4. Strategic initiatives
    • 10.4.8. mPulse Mobile
      • 10.4.8.1. Company overview
      • 10.4.8.2. Financial performance
      • 10.4.8.3. Product benchmarking
      • 10.4.8.4. Strategic initiatives
    • 10.4.9. AllazoHealth
      • 10.4.9.1. Company overview
      • 10.4.9.2. Financial performance
      • 10.4.9.3. Product benchmarking
      • 10.4.9.4. Strategic initiatives
    • 10.4.10. P360
      • 10.4.10.1. Company overview
      • 10.4.10.2. Financial performance
      • 10.4.10.3. Product benchmarking
      • 10.4.10.4. Strategic initiatives
    • 10.4.11. Brand Engagement Network, Inc.
      • 10.4.11.1. Company overview
      • 10.4.11.2. Financial performance
      • 10.4.11.3. Product benchmarking
      • 10.4.11.4. Strategic initiatives
    • 10.4.12. Oracle
      • 10.4.12.1. Company overview
      • 10.4.12.2. Financial performance
      • 10.4.12.3. Product benchmarking
      • 10.4.12.4. Strategic initiatives
    • 10.4.13. Nuance Communications Inc. (Microsoft)
      • 10.4.13.1. Company overview
      • 10.4.13.2. Financial performance
      • 10.4.13.3. Product benchmarking
      • 10.4.13.4. Strategic initiatives
    • 10.4.14. Health Catalyst
      • 10.4.14.1. Company overview
      • 10.4.14.2. Financial performance
      • 10.4.14.3. Product benchmarking
      • 10.4.14.4. Strategic initiatives
    • 10.4.15. Ada Health GmbH
      • 10.4.15.1. Company overview
      • 10.4.15.2. Financial performance
      • 10.4.15.3. Product benchmarking
      • 10.4.15.4. Strategic initiatives
    • 10.4.16. Aiva Inc.
      • 10.4.16.1. Company overview
      • 10.4.16.2. Financial performance
      • 10.4.16.3. Product benchmarking
      • 10.4.16.4. Strategic initiatives
    • 10.4.17. Claritas Rx
      • 10.4.17.1. Company overview
      • 10.4.17.2. Financial performance
      • 10.4.17.3. Product benchmarking
      • 10.4.17.4. Strategic initiatives
    • 10.4.18. AiCure
      • 10.4.18.1. Company overview
      • 10.4.18.2. Financial performance
      • 10.4.18.3. Product benchmarking
      • 10.4.18.4. Strategic initiatives
    • 10.4.19. UST Global Inc.
      • 10.4.19.1. Company overview
      • 10.4.19.2. Financial performance
      • 10.4.19.3. Product benchmarking
      • 10.4.19.4. Strategic initiatives
    • 10.4.20. ZS
      • 10.4.20.1. Company overview
      • 10.4.20.2. Financial performance
      • 10.4.20.3. Product benchmarking
      • 10.4.20.4. Strategic initiatives
    • 10.4.21. IQVIA, Inc.
      • 10.4.21.1. Company overview
      • 10.4.21.2. Financial performance
      • 10.4.21.3. Product benchmarking
      • 10.4.21.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America AI in patient engagement market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 4 North America AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 5 North America AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 6 North America AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 7 North America AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 U.S. AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 9 U.S. AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 10 U.S. AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 11 U.S. AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 12 U.S. AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 13 Canada AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 14 Canada AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 15 Canada AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 16 Canada AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 17 Canada AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 Mexico AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 19 Mexico AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 20 Mexico AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 21 Mexico AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 22 Mexico AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 Europe AI in patient engagement market, by region, 2018 - 2030 (USD Million)
  • Table 24 Europe AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 25 Europe AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 26 Europe AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Europe AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 28 Europe AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Germany AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 30 Germany AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 31 Germany AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 32 Germany AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 33 Germany AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 UK AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 35 UK AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 36 UK AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 37 UK AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 38 UK AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 France AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 40 France AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 41 France AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 42 France AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 43 France AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 Italy AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 45 Italy AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 46 Italy AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 47 Italy AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 48 Italy AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Spain AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 50 Spain AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 51 Spain AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 52 Spain AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 53 Spain AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Denmark AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 55 Denmark AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 56 Denmark AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 57 Denmark AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 58 Denmark AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Sweden AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 60 Sweden AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 61 Sweden AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 62 Sweden AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 63 Sweden AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 64 Norway AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 65 Norway AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 66 Norway AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 67 Norway AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 68 Norway AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Asia Pacific AI in patient engagement market, by region, 2018 - 2030 (USD Million)
  • Table 70 Asia Pacific AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 71 Asia Pacific AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 72 Asia Pacific AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 73 Asia Pacific AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 74 Asia Pacific AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 China AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 76 China AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 77 China AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 78 China AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 79 China AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 80 Japan AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 81 Japan AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 82 Japan AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 83 Japan AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 84 Japan AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 India AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 86 India AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 87 India AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 88 India AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 89 India AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 90 South Korea AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 91 South Korea AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 92 South Korea AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 93 South Korea AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 94 South Korea AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 95 Australia AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 96 Australia AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 97 Australia AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 98 Australia AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 99 Australia AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 100 Thailand AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 101 Thailand AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 102 Thailand AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 103 Thailand AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 104 Thailand AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 105 Latin America AI in patient engagement market, by region, 2018 - 2030 (USD Million)
  • Table 106 Latin America AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 107 Latin America AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 108 Latin America AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 109 Latin America AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 110 Latin America AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 111 Brazil AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 112 Brazil AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 113 Brazil AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 114 Brazil AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 115 Brazil AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 116 Argentina AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 117 Argentina AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 118 Argentina AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 119 Argentina AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 120 Argentina AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 121 MEA AI in patient engagement market, by region, 2018 - 2030 (USD Million)
  • Table 122 MEA AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 123 MEA AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 124 MEA AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 125 MEA AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 126 MEA AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 127 South Africa AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 128 South Africa AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 129 South Africa AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 130 South Africa AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 131 South Africa AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 132 Saudi Arabia AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 133 Saudi Arabia AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 134 Saudi Arabia AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 135 Saudi Arabia AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 136 Saudi Arabia AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 137 UAE AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 138 UAE AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 139 UAE AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 140 UAE AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 141 UAE AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 142 Kuwait AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 143 Kuwait AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 144 Kuwait AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 145 Kuwait AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 146 Kuwait AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Artificial intelligence in patient engagement market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Commodity flow analysis
  • Fig. 5 Parent market analysis
  • Fig. 6 Market snapshot
  • Fig. 7 Segment snapshot
  • Fig. 8 Segment snapshot
  • Fig. 9 Segment snapshot
  • Fig. 10 Competitive landscape snapshot
  • Fig. 11 AI in Patient Engagement Market Dynamics
  • Fig. 12 Major chatbot use cases in healthcare
  • Fig. 13 Advantages of omnichannel for pharmaceutical industry
  • Fig. 14 Key benefits of patient-centered care:
  • Fig. 15 Key challenges and strategies to maximize the potential of conversational AI in healthcare
  • Fig. 16 AI in patient engagement market: Porter's five forces analysis
  • Fig. 17 AI in patient engagement market: PESTLE analysis
  • Fig. 18 AI in patient engagement market, component outlook key takeaways (USD million)
  • Fig. 19 AI in patient engagement market: Technology movement analysis, 2023 & 2030 (USD Million)
  • Fig. 20 NLP market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Smart assistance market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 OCR market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Auto coding market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Text analytics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Speech analytics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Text analytics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 AI in patient engagement market, therapeutic outlook key takeaways (USD Million)
  • Fig. 29 AI in patient engagement market: Therapeutic area movement analysis, 2023 & 2030 (USD Million)
  • Fig. 30 Health & wellness market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Chronic disease management market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 AI in patient engagement market, functionality outlook key takeaways (USD Million)
  • Fig. 34 AI in patient engagement market: Functionality movement analysis, 2023 & 2030 (USD Million)
  • Fig. 35 Enhanced communication market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Patient education market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Chatbots and virtual health assistants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Predictive analytics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Administrative and streamlined operations market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 AI in patient engagement market, delivery type outlook key takeaways (USD million)
  • Fig. 42 AI in patient engagement market: Delivery type movement analysis, 2023 & 2030 (USD Million)
  • Fig. 43 Cloud-based market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 On-premise market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 AI in patient engagement market, end use outlook key takeaways (USD Million)
  • Fig. 46 AI in patient engagement market: End use movement analysis, 2023 & 2030 (USD Million)
  • Fig. 47 Healthcare providers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Healthcare payers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Regional outlook, 2023 & 2030
  • Fig. 51 Regional marketplace: Key takeaways
  • Fig. 52 Regional marketplace: Key takeaways
  • Fig. 53 North America: SWOT Analysis
  • Fig. 54 North America AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 55 U.S country dynamics
  • Fig. 56 U.S. AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 57 Canada country dynamics
  • Fig. 58 Canada AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 59 Mexico country dynamics
  • Fig. 60 Mexico AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 61 Europe: SWOT Analysis
  • Fig. 62 Europe AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 63 Germany country dynamics
  • Fig. 64 Germany AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 65 France country dynamics
  • Fig. 66 France AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 67 UK country dynamics
  • Fig. 68 UK AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 69 Italy country dynamics
  • Fig. 70 Italy AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 71 Spain country dynamics
  • Fig. 72 Spain AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 73 Denmark country dynamics
  • Fig. 74 Denmark AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 75 Sweden country dynamics
  • Fig. 76 Sweden AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 77 Norway country dynamics
  • Fig. 78 Norway AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 79 Asia Pacific: SWOT Analysis
  • Fig. 80 Asia Pacific AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 81 Japan country dynamics
  • Fig. 82 Japan AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 83 China country dynamics
  • Fig. 84 China AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 85 India country dynamics
  • Fig. 86 India AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 87 Australia country dynamics
  • Fig. 88 Australia AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 89 South Korea country dynamics
  • Fig. 90 South Korea AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 91 Thailand country dynamics
  • Fig. 92 Thailand AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 93 Latin America: SWOT Analysis
  • Fig. 94 Latin America AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 95 Brazil country dynamics
  • Fig. 96 Brazil AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 97 Argentina country dynamics
  • Fig. 98 Argentina AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 99 MEA: SWOT Analysis
  • Fig. 100 MEA AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 101 South Africa country dynamics
  • Fig. 102 South Africa AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 103 Saudi Arabia country dynamics
  • Fig. 104 Saudi Arabia AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 105 UAE country dynamics
  • Fig. 106 UAE AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 107 Kuwait country dynamics
  • Fig. 108 Kuwait AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 109 Key company categorization
  • Fig. 110 Company market position analysis
  • Fig. 111 Strategy mapping